The cost of inefficiencies in clinical trials
Clinical trials are expensive, time-sensitive, and closely monitored, with sponsors and contract research organisations (CROs) under pressure to run studies…
All articles by Alexander Love
Alexander Love
-
-
How Saudi Arabia is developing as a Middle East hub for clinical trials
Saudi Arabia is primed to emerge as the Middle East’s key hub for clinical trials, driven by both sustained state…
-
How eSource adoption is saving time and costs in clinical research
Clinical trial sites and sponsors are turning to eSource to ease pressures over costs and unlock efficiencies, with a recent…
-
The strategic investments expanding CDMO capabilities for HPAPIs and ADCs
As oncology pipelines continue to expand and targeted therapies become more sophisticated, contract development and manufacturing organisations (CDMOs) must invest…
-
The definitive infrastructure for modern drug development
Paradigm Health delivers a unified, AI-powered clinical research platform embedded within a national network of community and academic sites. By…
-
How the US healthcare system compares to other countries
The cost and quality of the US healthcare system remain prominent issues for many Americans. Despite spending nearly twice as…
-
Clinical trials: Are data managers ready for AI in EDC?
AI in clinical trials has the potential to offer faster insights, greater efficiency, and improved data quality. Nowhere is this…
-
How the AI shift is happening now in data management
The newest generation of AI-driven tools is beginning to reshape how clinical databases are built, governed, and maintained. This is…
-
OEB 6: The new standard in high-potent molecule manufacturing?
In recent years, the pharmaceutical industry has seen a significant increase in the development of highly potent active pharmaceutical ingredients…
-
Podcast: driving linked data insights, the complexities, and experiences
This is the final episode in season one of Insights Uncovered: A Real-World Data Podcast Series from GlobalData, presented by…